These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36790884)

  • 1. Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.
    Corsato Alvarenga I; Panickar KS; Hess H; McGrath S
    Annu Rev Anim Biosci; 2023 Feb; 11():227-246. PubMed ID: 36790884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation.
    Yu CHJ; Rupasinghe HPV
    Res Vet Sci; 2021 Nov; 140():38-46. PubMed ID: 34391060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical use of cannabidiol and cannabidiolic acid-rich hemp in veterinary medicine and lessons from human medicine.
    Ukai M; McGrath S; Wakshlag J
    J Am Vet Med Assoc; 2023 May; 261(5):623-631. PubMed ID: 36965472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials.
    Lima TM; Santiago NR; Alves ECR; Chaves DSA; Visacri MB
    Anim Health Res Rev; 2022 Jun; 23(1):25-38. PubMed ID: 35703023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats.
    Brutlag A; Hommerding H
    Vet Clin North Am Small Anim Pract; 2018 Nov; 48(6):1087-1102. PubMed ID: 30342565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
    Tambe SM; Mali S; Amin PD; Oliveira M
    J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications.
    Noreen N; Muhammad F; Akhtar B; Azam F; Anwar MI
    Crit Rev Eukaryot Gene Expr; 2018; 28(1):73-86. PubMed ID: 29773016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis.
    Henry JG; Shoemaker G; Prieto JM; Hannon MB; Wakshlag JJ
    Vet Comp Oncol; 2021 Jun; 19(2):253-265. PubMed ID: 33247539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
    Peng J; Fan M; An C; Ni F; Huang W; Luo J
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy.
    Boleti APA; Frihling BEF; E Silva PS; Cardoso PHO; de Moraes LFRN; Rodrigues TAA; Biembengute MEF; Koolen HHF; Migliolo L
    Neurosci Biobehav Rev; 2022 Jan; 132():1214-1228. PubMed ID: 33031814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.
    Campos AC; Moreira FA; Gomes FV; Del Bel EA; Guimarães FS
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3364-78. PubMed ID: 23108553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.
    Verrico CD; Wesson S; Konduri V; Hofferek CJ; Vazquez-Perez J; Blair E; Dunner K; Salimpour P; Decker WK; Halpert MM
    Pain; 2020 Sep; 161(9):2191-2202. PubMed ID: 32345916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
    Crippa JA; Guimarães FS; Campos AC; Zuardi AW
    Front Immunol; 2018; 9():2009. PubMed ID: 30298064
    [No Abstract]   [Full Text] [Related]  

  • 19. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.
    Chaves YC; Genaro K; Crippa JA; da Cunha JM; Zanoveli JM
    Metab Brain Dis; 2021 Apr; 36(4):639-652. PubMed ID: 33464458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Cellular Mechanisms of Action of Cannabidiol.
    Martinez Naya N; Kelly J; Corna G; Golino M; Abbate A; Toldo S
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.